These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9428448)

  • 1. Clinical correlates of hypertensive end-stage renal disease.
    Bleyer AJ; Chen R; D'Agostino RB; Appel RG
    Am J Kidney Dis; 1998 Jan; 31(1):28-34. PubMed ID: 9428448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease?
    Whittle JC; Whelton PK; Seidler AJ; Klag MJ
    Arch Intern Med; 1991 Jul; 151(7):1359-64. PubMed ID: 2064486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of hypertensive end-stage renal disease: effect of patient's race.
    Perneger TV; Whelton PK; Klag MJ; Rossiter KA
    Am J Epidemiol; 1995 Jan; 141(1):10-5. PubMed ID: 7801960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertensive end-stage renal disease in blacks: the role of end-stage renal disease surveillance.
    McClellan W
    Am J Kidney Dis; 1993 Apr; 21(4 Suppl 1):25-30. PubMed ID: 8465832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial differences in the incidence of end-stage renal disease.
    Tell GS; Hylander B; Craven TE; Burkart J
    Ethn Health; 1996 Mar; 1(1):21-31. PubMed ID: 9395545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension.
    McClellan W; Tuttle E; Issa A
    Am J Kidney Dis; 1988 Oct; 12(4):285-90. PubMed ID: 3263042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The low birth weight hypothesis as a plausible explanation for the black/white differences in hypertension, non-insulin-dependent diabetes, and end-stage renal disease.
    Lopes AA; Port FK
    Am J Kidney Dis; 1995 Feb; 25(2):350-6. PubMed ID: 7847366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged medicare beneficiaries.
    Xue JL; Eggers PW; Agodoa LY; Foley RN; Collins AJ
    J Am Soc Nephrol; 2007 Apr; 18(4):1299-306. PubMed ID: 17329578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical documentation of end-stage renal disease due to hypertension.
    Schlessinger SD; Tankersley MR; Curtis JJ
    Am J Kidney Dis; 1994 May; 23(5):655-60. PubMed ID: 8172207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality of blacks and whites with end-stage renal disease attributed to hypertension.
    Am J Kidney Dis; 1992 Nov; 20(5 Suppl 2):27-31. PubMed ID: 1442772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting racial differences in ESRD due to ADPKD in the United States.
    Murphy EL; Dai F; Blount KL; Droher ML; Liberti L; Crews DC; Dahl NK
    BMC Nephrol; 2019 Feb; 20(1):55. PubMed ID: 30764782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Projections of hypertension-related renal disease in middle-aged residents of the United States.
    Perneger TV; Klag MJ; Feldman HI; Whelton PK
    JAMA; 1993 Mar; 269(10):1272-7. PubMed ID: 8437305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between attributed cause of end-stage renal disease and risk of death in Brazilian patients receiving renal replacement therapy.
    Batista PB; Lopes AA; Costa FA
    Ren Fail; 2005; 27(6):651-6. PubMed ID: 16350813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. History of hypertension in patients treated for end-stage renal disease.
    Perneger TV; Whelton PK; Klag MJ
    J Hypertens; 1997 Apr; 15(4):451-6. PubMed ID: 9211180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid progression to end-stage renal disease in young hypertensive African Americans with proteinuria.
    Obialo CI; Hewan-Lowe K
    J Natl Med Assoc; 1998 Nov; 90(11):649-55. PubMed ID: 9828579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of end stage renal disease in African Americans with lupus nephritis.
    Franco C; Yoo W; Franco D; Xu Z
    Bull NYU Hosp Jt Dis; 2010; 68(4):251-6. PubMed ID: 21162701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating time to ESRD using kidney failure risk equations: results from the African American Study of Kidney Disease and Hypertension (AASK).
    Grams ME; Li L; Greene TH; Tin A; Sang Y; Kao WH; Lipkowitz MS; Wright JT; Chang AR; Astor BC; Appel LJ
    Am J Kidney Dis; 2015 Mar; 65(3):394-402. PubMed ID: 25441435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial factors in the incidence and causation of end-stage renal disease (ESRD).
    Easterling RE
    Trans Am Soc Artif Intern Organs; 1977; 23():28-33. PubMed ID: 910346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Troponin T as a Predictor of End-Stage Renal Disease and All-Cause Death in African Americans and Whites From Hypertensive Families.
    Hickson LJ; Rule AD; Butler KR; Schwartz GL; Jaffe AS; Bartley AC; Mosley TH; Turner ST
    Mayo Clin Proc; 2015 Nov; 90(11):1482-91. PubMed ID: 26494378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. End-stage renal disease in US minority groups.
    Feldman HI; Klag MJ; Chiapella AP; Whelton PK
    Am J Kidney Dis; 1992 May; 19(5):397-410. PubMed ID: 1585925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.